Response Biomedical Granted License by Health Canada to Market RSV Assay

Response Biomedical Monday announced that it has been granted a Class 3 (near patient/point-of-care) Medical Device license by Health Canada to market its Ramp Respiratory Syncytial Virus (RSV) Assay in Canada.
MarketWatch